Literature DB >> 26611556

Corticosteroids for Pain of Spinal Origin: Epidural and Intraarticular Administration.

Louisa S Schilling1, John D Markman2.   

Abstract

Targeted interventional delivery of corticosteroids remains a mainstay of treatment for spinal pain syndromes because this approach has a wider therapeutic index than other approaches. The best evidence for analgesic efficacy is in subacute radicular syndromes associated with new-onset or recurrent lumbar radiculitis. Complications often relate to drug delivery technique as much as actions of the steroid itself and require careful consideration and vigilance by the administering physician. Considerable uncertainty persists concerning which patients with chronic pain are most likely to benefit from corticosteroid injections. Matching this treatment option with specific spinal pain syndromes remains a major challenge.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Corticosteroid; Epidural steroid injection; Facet joint; Glucocorticoid; Low back pain; Lumbar stenosis; Sacroiliac joint; Transforaminal

Mesh:

Substances:

Year:  2016        PMID: 26611556     DOI: 10.1016/j.rdc.2015.08.003

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  3 in total

1.  Cryopreserved amniotic membrane and umbilical cord particulate for managing pain caused by facet joint syndrome: A case series.

Authors:  Daniel S Bennett
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

2.  Are steroids required in the treatment of ganglion impar blockade in chronic coccydynia? a prospective double-blinded clinical trial.

Authors:  Savas Sencan; Ipek Saadet Edipoglu; Fatma Gul Ulku Demir; Gunay Yolcu; Osman Hakan Gunduz
Journal:  Korean J Pain       Date:  2019-10-01

Review 3.  What Is New in the Clinical Management of Low Back Pain: A Narrative Review.

Authors:  Enrique Orrillo; Luis Vidal Neira; Fabián Piedimonte; Ricardo Plancarte Sanchez; Smiljan Astudilllo Mihovilovic; Marco Antonio Narvaez Tamayo; Martina Rekatsina; Giustino Varrassi
Journal:  Cureus       Date:  2022-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.